# Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells

> **NCT05017298** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Celltex Therapeutics Corporation** · enrollment: 30 (estimated)

## Conditions studied

- Corona Virus Infection
- Covid19

## Interventions

- **BIOLOGICAL:** Allogeneic adipose-derived stem cells

## Key facts

- **NCT ID:** NCT05017298
- **Lead sponsor:** Celltex Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2024-11-01
- **Final completion:** 2026-11-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017298, "Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05017298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*